brunel healthcare manufacturing limited
brunel healthcare manufacturing limited Company Information
Company Number
04504895
Next Accounts
Sep 2025
Industry
Manufacture of homogenised food preparations and dietetic food
Manufacture of basic pharmaceutical products
Shareholders
aland nutrition europe bv
Group Structure
View All
Contact
Registered Address
william nadin way, swadlincote, derbyshire, DE11 0BB
Website
www.brunelhealthcare.co.ukbrunel healthcare manufacturing limited Estimated Valuation
Pomanda estimates the enterprise value of BRUNEL HEALTHCARE MANUFACTURING LIMITED at £116.1m based on a Turnover of £93.9m and 1.24x industry multiple (adjusted for size and gross margin).
brunel healthcare manufacturing limited Estimated Valuation
Pomanda estimates the enterprise value of BRUNEL HEALTHCARE MANUFACTURING LIMITED at £55m based on an EBITDA of £8.3m and a 6.66x industry multiple (adjusted for size and gross margin).
brunel healthcare manufacturing limited Estimated Valuation
Pomanda estimates the enterprise value of BRUNEL HEALTHCARE MANUFACTURING LIMITED at £37.2m based on Net Assets of £20.8m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Brunel Healthcare Manufacturing Limited Overview
Brunel Healthcare Manufacturing Limited is a live company located in derbyshire, DE11 0BB with a Companies House number of 04504895. It operates in the manufacture of homogenized food preparations and dietetic food sector, SIC Code 10860. Founded in August 2002, it's largest shareholder is aland nutrition europe bv with a 100% stake. Brunel Healthcare Manufacturing Limited is a mature, large sized company, Pomanda has estimated its turnover at £93.9m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Brunel Healthcare Manufacturing Limited Health Check
Pomanda's financial health check has awarded Brunel Healthcare Manufacturing Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
7 Weak
Size
annual sales of £93.9m, make it larger than the average company (£33.2m)
£93.9m - Brunel Healthcare Manufacturing Limited
£33.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a slower rate (12.6%)
9% - Brunel Healthcare Manufacturing Limited
12.6% - Industry AVG
Production
with a gross margin of 8.7%, this company has a higher cost of product (32.7%)
8.7% - Brunel Healthcare Manufacturing Limited
32.7% - Industry AVG
Profitability
an operating margin of 3.5% make it less profitable than the average company (5.9%)
3.5% - Brunel Healthcare Manufacturing Limited
5.9% - Industry AVG
Employees
with 497 employees, this is above the industry average (93)
497 - Brunel Healthcare Manufacturing Limited
93 - Industry AVG
Pay Structure
on an average salary of £40k, the company has a lower pay structure (£53.4k)
£40k - Brunel Healthcare Manufacturing Limited
£53.4k - Industry AVG
Efficiency
resulting in sales per employee of £188.8k, this is less efficient (£352.9k)
£188.8k - Brunel Healthcare Manufacturing Limited
£352.9k - Industry AVG
Debtor Days
it gets paid by customers after 71 days, this is near the average (59 days)
71 days - Brunel Healthcare Manufacturing Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 35 days, this is close to average (39 days)
35 days - Brunel Healthcare Manufacturing Limited
39 days - Industry AVG
Stock Days
it holds stock equivalent to 158 days, this is more than average (86 days)
158 days - Brunel Healthcare Manufacturing Limited
86 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (10 weeks)
1 weeks - Brunel Healthcare Manufacturing Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 75.2%, this is a higher level of debt than the average (42.7%)
75.2% - Brunel Healthcare Manufacturing Limited
42.7% - Industry AVG
BRUNEL HEALTHCARE MANUFACTURING LIMITED financials
Brunel Healthcare Manufacturing Limited's latest turnover from December 2023 is £93.9 million and the company has net assets of £20.8 million. According to their latest financial statements, Brunel Healthcare Manufacturing Limited has 497 employees and maintains cash reserves of £1.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 93,858,000 | 83,830,000 | 80,203,000 | 72,420,000 | 59,580,000 | 51,204,000 | 46,765,000 | 33,296,000 | 39,250,000 | 38,331,000 | 35,334,000 | 31,126,000 | 28,767,000 | 34,971,000 | 26,162,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 85,689,000 | 74,777,000 | 72,923,000 | 62,503,000 | 54,309,000 | 46,814,000 | 42,178,000 | 31,790,000 | 37,893,000 | 27,048,000 | 24,477,000 | 21,893,000 | 21,379,000 | 26,435,000 | 18,531,000 |
| Gross Profit | 8,169,000 | 9,053,000 | 7,280,000 | 9,917,000 | 5,271,000 | 4,390,000 | 4,587,000 | 1,506,000 | 1,357,000 | 11,283,000 | 10,857,000 | 9,233,000 | 7,388,000 | 8,536,000 | 7,631,000 |
| Admin Expenses | 4,920,000 | 5,190,000 | 4,232,000 | 4,894,000 | 2,959,000 | 2,636,000 | 2,678,000 | 1,302,000 | 2,240,000 | 9,255,000 | 9,240,000 | 8,178,000 | 7,563,000 | 10,541,000 | 6,605,000 |
| Operating Profit | 3,249,000 | 3,863,000 | 3,048,000 | 5,023,000 | 2,312,000 | 1,754,000 | 1,909,000 | 204,000 | -883,000 | 2,028,000 | 1,617,000 | 1,055,000 | -175,000 | -2,005,000 | 1,026,000 |
| Interest Payable | 2,171,000 | 1,271,000 | 848,000 | 812,000 | 883,000 | 437,000 | 260,000 | 380,000 | 587,000 | 528,000 | 478,000 | 476,000 | 374,000 | 327,000 | 9,000 |
| Interest Receivable | 9,000 | 5,000 | 2,000 | 320,000 | 413,000 | 19,000 | 18,000 | 83,000 | 159,000 | 155,000 | 133,000 | 117,000 | 108,000 | 108,000 | 1,000 |
| Pre-Tax Profit | 1,087,000 | 2,597,000 | 2,202,000 | 4,531,000 | 1,842,000 | 1,336,000 | 1,846,000 | 4,230,000 | -7,614,000 | 1,655,000 | 1,272,000 | 696,000 | -441,000 | -2,224,000 | 1,018,000 |
| Tax | -302,000 | -511,000 | -710,000 | -864,000 | -243,000 | -263,000 | -332,000 | 21,000 | 262,000 | -357,000 | -343,000 | -4,000 | 119,000 | -11,000 | -71,000 |
| Profit After Tax | 785,000 | 2,086,000 | 1,492,000 | 3,667,000 | 1,599,000 | 1,073,000 | 1,514,000 | 4,251,000 | -7,352,000 | 1,298,000 | 929,000 | 692,000 | -322,000 | -2,235,000 | 947,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 785,000 | 2,086,000 | 1,492,000 | 3,667,000 | 1,599,000 | 1,073,000 | 1,514,000 | 4,251,000 | -7,352,000 | 1,298,000 | 929,000 | 692,000 | -322,000 | -2,235,000 | 947,000 |
| Employee Costs | 19,885,000 | 17,403,000 | 16,798,000 | 15,174,000 | 13,172,000 | 11,609,000 | 11,157,000 | 8,097,000 | 9,975,000 | 8,394,000 | 6,986,000 | 6,246,000 | 5,766,000 | 6,948,000 | 5,265,000 |
| Number Of Employees | 497 | 485 | 504 | 444 | 420 | 391 | 389 | 389 | 365 | 304 | 259 | 232 | 227 | 208 | 181 |
| EBITDA* | 8,250,000 | 8,331,000 | 5,467,000 | 6,970,000 | 4,056,000 | 3,064,000 | 2,982,000 | 988,000 | -138,000 | 2,492,000 | 1,989,000 | 1,482,000 | 260,000 | -1,464,000 | 1,484,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 11,803,000 | 13,041,000 | 25,391,000 | 21,248,000 | 20,557,000 | 10,581,000 | 8,350,000 | 6,708,000 | 6,987,000 | 6,423,000 | 2,578,000 | 1,796,000 | 1,946,000 | 1,609,000 | 1,981,000 |
| Intangible Assets | 11,392,000 | 11,213,000 | 1,747,000 | 1,550,000 | 1,216,000 | 980,000 | 742,000 | 650,000 | 620,000 | 1,554,000 | 1,409,000 | 1,137,000 | 540,000 | 540,000 | 540,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 23,195,000 | 24,254,000 | 27,138,000 | 22,798,000 | 21,773,000 | 11,561,000 | 9,092,000 | 7,358,000 | 7,607,000 | 7,977,000 | 3,987,000 | 2,933,000 | 2,486,000 | 2,149,000 | 2,521,000 |
| Stock & work in progress | 37,253,000 | 30,384,000 | 25,288,000 | 18,805,000 | 15,341,000 | 15,245,000 | 11,913,000 | 10,789,000 | 9,595,000 | 9,464,000 | 8,565,000 | 8,407,000 | 6,927,000 | 6,805,000 | 7,554,000 |
| Trade Debtors | 18,279,000 | 17,425,000 | 13,845,000 | 16,361,000 | 12,919,000 | 11,669,000 | 8,924,000 | 10,651,000 | 9,472,000 | 8,869,000 | 6,675,000 | 6,637,000 | 5,125,000 | 6,047,000 | 4,142,000 |
| Group Debtors | 1,897,000 | 971,000 | 436,000 | 0 | 678,000 | 40,000 | 41,000 | 522,000 | 0 | 6,456,000 | 5,795,000 | 4,870,000 | 4,438,000 | 4,456,000 | 0 |
| Misc Debtors | 2,070,000 | 623,000 | 890,000 | 2,860,000 | 583,000 | 1,255,000 | 1,676,000 | 0 | 0 | 846,000 | 738,000 | 585,000 | 525,000 | 654,000 | 374,000 |
| Cash | 1,353,000 | 1,364,000 | 823,000 | 1,279,000 | 504,000 | 251,000 | 1,729,000 | 2,059,000 | 0 | 352,000 | 294,000 | 102,000 | 102,000 | 312,000 | 736,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 60,901,000 | 51,282,000 | 41,903,000 | 39,305,000 | 30,025,000 | 28,460,000 | 24,283,000 | 24,021,000 | 19,110,000 | 25,987,000 | 22,067,000 | 20,601,000 | 17,117,000 | 18,274,000 | 12,806,000 |
| total assets | 84,096,000 | 75,536,000 | 69,041,000 | 62,103,000 | 51,798,000 | 40,021,000 | 33,375,000 | 31,379,000 | 26,717,000 | 33,964,000 | 26,054,000 | 23,534,000 | 19,603,000 | 20,423,000 | 15,327,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 20,397,000 | 17,003,000 | 11,122,000 | 6,908,000 | 3,539,000 | 6,090,000 | 1,750,000 | 0 | 9,918,000 | 9,360,000 | 6,781,000 | 5,438,000 | 4,608,000 | 6,299,000 | 0 |
| Trade Creditors | 8,425,000 | 6,797,000 | 4,946,000 | 6,825,000 | 7,010,000 | 6,465,000 | 5,492,000 | 6,678,000 | 7,390,000 | 8,035,000 | 0 | 0 | 4,314,000 | 4,010,000 | 4,245,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 2,342,000 | 1,845,000 | 1,760,000 | 1,370,000 | 1,229,000 | 0 | 0 | 0 | 205,000 | 188,000 | 0 | 0 | 0 | 0 | 57,000 |
| other current liabilities | 8,247,000 | 7,941,000 | 6,684,000 | 8,210,000 | 9,037,000 | 6,695,000 | 5,712,000 | 5,920,000 | 1,210,000 | 7,898,000 | 13,589,000 | 13,470,000 | 6,604,000 | 4,430,000 | 4,227,000 |
| total current liabilities | 39,411,000 | 33,586,000 | 24,512,000 | 23,313,000 | 20,815,000 | 19,250,000 | 12,954,000 | 12,598,000 | 18,723,000 | 25,481,000 | 20,370,000 | 18,908,000 | 15,526,000 | 14,739,000 | 8,529,000 |
| loans | 16,432,000 | 19,176,000 | 25,238,000 | 19,570,000 | 18,692,000 | 2,046,000 | 0 | 0 | 936,000 | 573,000 | 0 | 6,000 | 18,000 | 588,000 | 0 |
| hp & lease commitments | 7,020,000 | 7,496,000 | 9,159,000 | 8,017,000 | 7,702,000 | 0 | 0 | 0 | 468,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 460,000 | 132,000 | 0 | 0 | 0 | 0 |
| other liabilities | 13,041,000 | 9,925,000 | 11,641,000 | 10,813,000 | 12,416,000 | 12,257,000 | 14,088,000 | 14,155,000 | 7,093,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 5,206,000 | 4,794,000 | 4,630,000 | 3,460,000 | 2,872,000 | 2,610,000 | 2,440,000 | 2,054,000 | 2,170,000 | 1,500,000 | 300,000 | 300,000 | 574,000 | 2,574,000 | 920,000 |
| total long term liabilities | 23,860,000 | 21,910,000 | 26,575,000 | 22,328,000 | 23,198,000 | 14,585,000 | 15,308,000 | 15,182,000 | 8,646,000 | 1,783,000 | 282,000 | 153,000 | 296,000 | 1,581,000 | 460,000 |
| total liabilities | 63,271,000 | 55,496,000 | 51,087,000 | 45,641,000 | 44,013,000 | 33,835,000 | 28,262,000 | 27,780,000 | 27,369,000 | 27,264,000 | 20,652,000 | 19,061,000 | 15,822,000 | 16,320,000 | 8,989,000 |
| net assets | 20,825,000 | 20,040,000 | 17,954,000 | 16,462,000 | 7,785,000 | 6,186,000 | 5,113,000 | 3,599,000 | -652,000 | 6,700,000 | 5,402,000 | 4,473,000 | 3,781,000 | 4,103,000 | 6,338,000 |
| total shareholders funds | 20,825,000 | 20,040,000 | 17,954,000 | 16,462,000 | 7,785,000 | 6,186,000 | 5,113,000 | 3,599,000 | -652,000 | 6,700,000 | 5,402,000 | 4,473,000 | 3,781,000 | 4,103,000 | 6,338,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 3,249,000 | 3,863,000 | 3,048,000 | 5,023,000 | 2,312,000 | 1,754,000 | 1,909,000 | 204,000 | -883,000 | 2,028,000 | 1,617,000 | 1,055,000 | -175,000 | -2,005,000 | 1,026,000 |
| Depreciation | 2,675,000 | 2,573,000 | 2,419,000 | 1,947,000 | 1,718,000 | 1,310,000 | 1,073,000 | 784,000 | 745,000 | 464,000 | 372,000 | 427,000 | 435,000 | 541,000 | 458,000 |
| Amortisation | 2,326,000 | 1,895,000 | 0 | 0 | 26,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -302,000 | -511,000 | -710,000 | -864,000 | -243,000 | -263,000 | -332,000 | 21,000 | 262,000 | -357,000 | -343,000 | -4,000 | 119,000 | -11,000 | -71,000 |
| Stock | 6,869,000 | 5,096,000 | 6,483,000 | 3,464,000 | 96,000 | 3,332,000 | 1,124,000 | 1,325,000 | 131,000 | 899,000 | 158,000 | 1,480,000 | 122,000 | 6,805,000 | 7,554,000 |
| Debtors | 3,227,000 | 3,848,000 | -4,050,000 | 5,041,000 | 1,216,000 | 2,323,000 | -532,000 | -4,998,000 | -6,699,000 | 2,963,000 | 1,116,000 | 2,004,000 | -1,069,000 | 11,157,000 | 4,516,000 |
| Creditors | 1,628,000 | 1,851,000 | -1,879,000 | -185,000 | 545,000 | 973,000 | -1,186,000 | -1,357,000 | -645,000 | 8,035,000 | 0 | -4,314,000 | 304,000 | 4,010,000 | 4,245,000 |
| Accruals and Deferred Income | 306,000 | 1,257,000 | -1,526,000 | -827,000 | 2,342,000 | 983,000 | -208,000 | -2,438,000 | -7,148,000 | -5,363,000 | 251,000 | 6,866,000 | 2,174,000 | 4,430,000 | 4,227,000 |
| Deferred Taxes & Provisions | 412,000 | 164,000 | 1,170,000 | 588,000 | 262,000 | 170,000 | 386,000 | 554,000 | 670,000 | 1,200,000 | 0 | -274,000 | -2,000,000 | 2,574,000 | 920,000 |
| Cash flow from operations | 198,000 | 2,148,000 | 89,000 | -2,823,000 | 5,650,000 | -728,000 | 1,050,000 | 1,441,000 | -431,000 | 2,145,000 | 623,000 | 272,000 | 1,804,000 | -8,423,000 | -1,265,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 3,394,000 | 5,881,000 | 4,214,000 | 3,369,000 | -2,551,000 | 4,340,000 | 1,750,000 | -9,360,000 | 558,000 | 2,579,000 | 1,343,000 | 830,000 | -1,691,000 | 6,299,000 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -2,744,000 | -6,062,000 | 5,668,000 | 878,000 | 16,646,000 | 2,046,000 | 0 | -573,000 | 363,000 | 573,000 | -6,000 | -12,000 | -570,000 | 588,000 | 0 |
| Hire Purchase and Lease Commitments | 21,000 | -1,578,000 | 1,532,000 | 456,000 | 8,931,000 | 0 | 0 | -188,000 | 485,000 | 188,000 | 0 | 0 | 0 | 0 | 57,000 |
| other long term liabilities | 3,116,000 | -1,716,000 | 828,000 | -1,603,000 | 159,000 | -1,831,000 | -67,000 | 14,155,000 | 7,093,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | -2,162,000 | -1,266,000 | -846,000 | -492,000 | -470,000 | -418,000 | -242,000 | -297,000 | -428,000 | -373,000 | -345,000 | -359,000 | -266,000 | -219,000 | -8,000 |
| cash flow from financing | 1,625,000 | -4,741,000 | 11,396,000 | 7,618,000 | 22,715,000 | 4,137,000 | 1,441,000 | -3,615,000 | 8,071,000 | 2,967,000 | 992,000 | 459,000 | -2,527,000 | 13,006,000 | 5,440,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -11,000 | 541,000 | -456,000 | 775,000 | 253,000 | -1,478,000 | -330,000 | 1,707,000 | -352,000 | 58,000 | 192,000 | 0 | -210,000 | 312,000 | 736,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -11,000 | 541,000 | -456,000 | 775,000 | 253,000 | -1,478,000 | -330,000 | 1,707,000 | -352,000 | 58,000 | 192,000 | 0 | -210,000 | 312,000 | 736,000 |
brunel healthcare manufacturing limited Credit Report and Business Information
Brunel Healthcare Manufacturing Limited Competitor Analysis
Perform a competitor analysis for brunel healthcare manufacturing limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in DE11 area or any other competitors across 12 key performance metrics.
brunel healthcare manufacturing limited Ownership
BRUNEL HEALTHCARE MANUFACTURING LIMITED group structure
Brunel Healthcare Manufacturing Limited has 7 subsidiary companies.
Ultimate parent company
ALAND HEALTH HOLDING LTD
#0034416
ALAND NUTRITION EUROPE BV
#0101821
2 parents
BRUNEL HEALTHCARE MANUFACTURING LIMITED
04504895
7 subsidiaries
brunel healthcare manufacturing limited directors
Brunel Healthcare Manufacturing Limited currently has 5 directors. The longest serving directors include Mr John Hackett (Jan 2012) and Mr James Amery (Sep 2012).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr John Hackett | 57 years | Jan 2012 | - | Director | |
| Mr James Amery | England | 49 years | Sep 2012 | - | Director |
| Mr Matthew Woodings | 54 years | Oct 2013 | - | Director | |
| Mr Robert Haytack | 46 years | Oct 2013 | - | Director | |
| Mr Richard Fielding | 56 years | Jan 2019 | - | Director |
P&L
December 2023turnover
93.9m
+12%
operating profit
3.2m
-16%
gross margin
8.8%
-19.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
20.8m
+0.04%
total assets
84.1m
+0.11%
cash
1.4m
-0.01%
net assets
Total assets minus all liabilities
brunel healthcare manufacturing limited company details
company number
04504895
Type
Private limited with Share Capital
industry
10860 - Manufacture of homogenised food preparations and dietetic food
21100 - Manufacture of basic pharmaceutical products
incorporation date
August 2002
age
22
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
perrigo uk limited (June 2008)
peter black pharmaceuticals limited (December 2003)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
william nadin way, swadlincote, derbyshire, DE11 0BB
Bank
BARCLAYS BANK PLC
Legal Advisor
-
brunel healthcare manufacturing limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 24 charges/mortgages relating to brunel healthcare manufacturing limited. Currently there are 8 open charges and 16 have been satisfied in the past.
brunel healthcare manufacturing limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BRUNEL HEALTHCARE MANUFACTURING LIMITED. This can take several minutes, an email will notify you when this has completed.
brunel healthcare manufacturing limited Companies House Filings - See Documents
| date | description | view/download |
|---|
